Document Detail


A Preliminary Report on the Usage of an Intracorporal Antibiotic Cast with Synthetic High Purity CaSO4 for the Treatment of Infected Penile Implant.
MedLine Citation:
PMID:  23347377     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
INTRODUCTION: Currently, the surgical treatment of infected penile prostheses is complete removal and either immediate salvage procedure, which carries a significant infection risk, or delayed implantation. With delayed implantation the risk of infection is lower, but the patient loses penile length and width due to corporal fibrosis. AIM: We present our experience with the use of a novel temporary synthetic high purity calcium sulfate (SHPCaSO4) component that acts as a "spacer" at the time of removal of an infected prosthesis while providing constant delivery of local antibiotic elution to the infected area. MAIN OUTCOME MEASURES: Demonstrate that the use of a novel material, SHPCaSO4, can be an innovative way to bridge the gap between removal of an infected penile implant and delayed reimplantation. METHODS: Two patients (Patient A and B) presented with pain and erythema and were found to have infected malleable penile prosthesis. Both underwent removal of all infected components, and sent for tissue culture. The SHPCaSO4 was mixed with vancomycin and tobramycin, allowed to set up for 5 minutes, and then injected into the corporal space followed by closure with 2-0 Vicryl sutures. The injected SHPCaSO4 was palpable in the penile shaft both proximally and distally, as an "intracorporal casts." RESULTS: Patients denied pain postoperatively. Delayed implantation occurred at 6 weeks for patient A. This went uneventful and a new three-piece inflatable implant was inserted. Patient B underwent salvage placement of right malleable implant at 15 weeks, and here significant corporal fibrosis was encountered. Patients have had no infection since their delayed implantation (mean follow-up 4 months). CONCLUSIONS: Data in reference to SHPCaSO4 shows that this product dissolves in approximately 4-6 weeks. This may account for the difference in the ease of delayed implantation between the two patients. Further investigation is warranted.
Authors:
Kelly Swords; Daniel R Martinez; Jorge L Lockhart; Rafael Carrion
Related Documents :
24767897 - Mini-implants as provisional anchorage for the replacement of missing anterior teeth: a...
24390027 - Prevalence and characterıstıcs of supernumerary teeth in a child population from cent...
24493187 - Increased risk of revision for high flexion total knee replacement with thicker tibial ...
23823347 - Analysis of total microbiota in dentin after mechanical or papain-based chemomechanical...
16240417 - Effect of er:yag laser on enamel acid resistance: morphological and atomic spectrometry...
22518377 - Posterior atrophic jaws rehabilitated with prostheses supported by 6 mm-long, 4 mm-wide...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-24
Journal Detail:
Title:  The journal of sexual medicine     Volume:  -     ISSN:  1743-6109     ISO Abbreviation:  J Sex Med     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101230693     Medline TA:  J Sex Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 International Society for Sexual Medicine.
Affiliation:
Department of Urology, University of South Florida, Tampa, FL,, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A RING-Type E3 ligase controls anther dehiscence by activating the jasmonate biosynthetic pathway ge...
Next Document:  Introduction to optical methods for characterizing liquid crystals at interfaces.